We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Common Biocide Promotes Bacteria in Nasal Passages

By HospiMedica International staff writers
Posted on 24 Apr 2014
Triclosan, an antimicrobial agent found in common household soaps, shampoos, and toothpastes promotes the colonization of Staphylococcus aureus in noses, according to a new study.

Researchers at the University of Michigan (Ann Arbor, USA) conducted a study that examined the nasal passages of healthy adults, which found that 41% of those sampled had traces of triclosan in their nasal secretions; the presence of triclosan in the secretions also trended positively with nasal colonization by S. More...
aureus. Additional experiments found that S. aureus grown in the presence of triclosan was better able to attach to human proteins, and that rats exposed to triclosan were more susceptible to S. aureus nasal colonization.

The researchers also demonstrated that triclosan could promote the binding of S. aureus to host proteins such as collagen, fibronectin, and keratin, as well as inanimate surfaces such as plastic and glass. According to the researchers, the data contributes to the growing body of research that demonstrates the unintended consequences of unregulated triclosan, as well as the inadvertent effects of triclosan on the environment and human health, since it also decreases circulating levels of thyroxine hormone (T4), which could lead to altered behavior, learning disabilities, and infertility. The study was published on April 8, 2014, in mBio.

“Triclosan has been around for the past 40 years. It's really common in hand soaps, toothpastes, and mouthwashes but there's no evidence it does a better job than regular soap,” said senior author Blaise Boles, PhD, an assistant professor of molecular, cellular and developmental biology. “This agent may have unintended consequences in our bodies. It could promote S. aureus nasal colonization, putting some people at increased risk for infection.”

Triclosan is a polychlorophenoxyphenol antibacterial and antifungal agent that has been shown to be effective in reducing and controlling bacterial contamination on the hands and on treated products. In use since 1972, triclosan is also found in health care settings, such as in surgical scrubs and personnel hand washes. More recently, showering or bathing with 2% triclosan has become a recommended regimen in surgical units for the decolonization of patients whose skin carries methicillin-resistant Staphylococcus aureus (MRSA).

Related Links:

University of Michigan



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
IV Therapy Cart
Avalo I.V Therapy Cart
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.